IP Library Granted Patent US 7,223,399
Granted Patent B2
US 7,223,399 · App. 11/345,736 · Granted May 29, 2007

Methods for treating restenosis with a

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,223,399
App. No.
11/345,736
Granted
May 29, 2007
Kind
B2
Abstract

The present invention provides for methods of treating cardiovascular diseases in a mammal. The methods include a step of administering an effective amount of a botulinum toxin directly to a blood vessel of a mammal thereby treating a cardiovascular disease.

Claims (14)

1. A method for treating restenosis in a patient, the method comprising the steps of: (a) administering an effective amount of a botulinum neurotoxin directly into the wall of the patient's blood vessel in the area of the restenosis prior to performing an angioplasty procedure; and (b) performing the angioplasty procedure, thereby treating restenosis in the patient.

2. The method of claim 1 , wherein the administering of the botulinum neurotoxin is effective in reducing or eliminating restenosis following an angioplasty procedure.

3. The method of claim 1 , wherein the angioplasty does not include the step of inserting a stent into the blood vessel.

4. The method of claim 1 , wherein the administering of the botulinum neurotoxin reduces or eliminates damage to a blood vessel.

5. The method of claim 1 , wherein the administering of the botulinum is effective in dilating the blood vessel.

6. The method of claim 1 , wherein the administering of the botulinum is effective in reducing or eliminating inflammation the blood vessel.

7. The method of claim 1 , wherein the botulinum neurotoxin is selected from the group consisting of botulinum neurotoxin types A, B, C, D, E, F, G, and combinations thereof.

8. The method of claim 1 , wherein the botulinum neurotoxin is botulinum neurotoxin type A.

9. The method of claim 1 , further comprising inserting a stent, having botulinum neurotoxin coated or impregnated thereon, into the blood vessel after administering the botulinum neurotoxin.

10. A method for treating restenosis in a patient, the method comprising the step of administering an effective amount of a botulinum neurotoxin type A to a blood vessel of the patient having restenosis prior to performing an angioplasty procedure; and performing the angioplasty procedure, thereby treating the restenosis in the patient.

11. The method of claim 10 , wherein the botulinum neurotoxin type A is administered to a blood vessel wall at or near the restenosis.

12. The method of claim 10 , wherein the administering comprises injecting the botulinum neurotoxin type A into a blood vessel wall.

13. The method of claim 10 , further comprising inserting a botulinum neurotoxin type A coated or impregnated stent at or near the restenosis.

14. The method of claim 10 , further comprising inserting a stent at or near the restenosis.